Home Cart Sign in  
Chemical Structure| 24868-20-0 Chemical Structure| 24868-20-0

Structure of 24868-20-0

Chemical Structure| 24868-20-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dantrolene Sodium is a skeletal muscle relaxant which acts by blocking muscle contraction beyond the neuromuscular junction.

Synonyms: Dantrolene sodium hydrate; Dantrium; F-440

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dantrolene sodium hemiheptahydrate

CAS No. :24868-20-0
Formula : C28H32N8Na2O17
M.W : 798.58
SMILES Code : [H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].[H]O[H].O=C(CN1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+]([O-])=O)[N-]C1=O.O=C(CN4N=CC5=CC=C(O5)C6=CC=C(C=C6)[N+]([O-])=O)[N-]C4=O.[Na+].[Na+]
Synonyms :
Dantrolene sodium hydrate; Dantrium; F-440
MDL No. :MFCD07357270

Safety of Dantrolene sodium hemiheptahydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
YAC128 MSNs 100 nM 1 hour To evaluate the protective effects of dantrolene on glutamate-induced excitotoxicity in YAC128 MSNs, results showed that dantrolene pretreatment significantly reduced glutamate-induced apoptosis Mol Neurodegener. 2011 Nov 25;6:81.
CPVT-iPSC-derived cardiomyocytes 10 µM 10–15 minutes Dantrolene restored normal Ca2+ spark properties and rescued the arrhythmogenic phenotype in CPVT-iPSC-derived cardiomyocytes under basal conditions and corrected S406L-RYR2 hyperactivity induced by adrenergic stimulation. EMBO Mol Med. 2012 Mar;4(3):180-91.
Rat fetal cortical neurons 40 µM 12 hours To evaluate the protective effect of dantrolene and hypothermia on oxygen-glucose deprivation/reoxygenation (OGD/R)-induced neuronal injury. Results showed that the combination of dantrolene and hypothermia significantly increased neuronal survival, reduced intracellular reactive oxygen species, cytoplasmic histone-associated DNA fragmentation, and apoptosis. Neural Regen Res. 2015 Aug;10(8):1279-85.
Rat mesenteric lymphatic vessels 3 µM 20 minutes Dantrolene prevents DOX-induced 'calcium leak' and maintains rhythmic lymphatic contractions Front Pharmacol. 2021 Aug 16;12:727526.
Induced pluripotent stem cells (iPSCs) 30 µM 24 hours Dantrolene significantly promoted cell viability in iPSCs derived from sporadic Alzheimer’s disease (SAD) and familial Alzheimer’s disease (FAD) patients. Anesthesiology. 2020 May;132(5):1062-1079.
Primary Darier disease patient fibroblasts (DDF) 10 µM 24 hours Dantrolene significantly helped retain ER-Ca2+ levels. EMBO Mol Med. 2024 Sep;16(9):1986-2001.
Primary Darier disease patient keratinocytes (DDK) 10 µM 24 hours Dantrolene significantly reduced baseline and peak levels of cytoplasmic Ca2+ and increased baseline ER-Ca2+ levels, inhibiting Ca2+ efflux. EMBO Mol Med. 2024 Sep;16(9):1986-2001.
Human epidermal keratinocyte (HEKa) 10 µM 24 hours Dantrolene significantly reduced baseline and peak levels of cytoplasmic Ca2+ and increased baseline ER-Ca2+ levels, inhibiting Ca2+ efflux. EMBO Mol Med. 2024 Sep;16(9):1986-2001.
Basal forebrain cholinergic neurons 30 µM 3 days Dantrolene significantly ameliorated the impairment of basal forebrain cholinergic neurons differentiation in both SAD and FAD cells. Anesthesiology. 2020 May;132(5):1062-1079.
Cortical neurons 30 µM 3 days Dantrolene significantly ameliorated the impairment of cortical neurons differentiation in both SAD and FAD cells. Anesthesiology. 2020 May;132(5):1062-1079.
Neuroprogenitor cells 30 µM 3 days Dantrolene significantly ameliorated the impairment of neuroprogenitor cells differentiation into immature neurons in both SAD and FAD cells. Anesthesiology. 2020 May;132(5):1062-1079.
Cardiomyocytes 10 µM 30 minutes To evaluate the effect of Dantrolene on spontaneous SR Ca2+ release, results showed Dantrolene reduced spontaneous Ca2+ release events. J Mol Cell Cardiol. 2023 Aug;181:67-78.
RyR2 channels 10 µM To test the inhibitory effect of Dantrolene on RyR2, found that its inhibition depends on the presence of FKBP12.6 J Gen Physiol. 2023 Aug 7;155(8):e202213277.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Anesthetized rat mesenteric lymph circulation model Local mesenteric superfusion 10 µM Administered 20 min prior to and continuously after DOX infusion Dantrolene prevents DOX-induced lymphostasis and maintains lymph flow Front Pharmacol. 2021 Aug 16;12:727526.
Wistar rat pups KA-induced status epilepticus model Intraperitoneal injection 10 mg/kg Two injections, 1 hour apart To investigate the protective effect of Dantrolene against KA-induced neuronal apoptosis. Results showed that Dantrolene significantly reduced the number of apoptotic cells in hippocampal CA1 region and parietal cortex. J Cell Mol Med. 2002 Oct-Dec;6(4):555-69
C57BL/6J mice Chronic ischemic heart disease model Subcutaneous osmotic pump 20 mg/kg Continuous for 6 weeks To evaluate the effect of Dantrolene on ventricular tachycardia and cardiac function, results showed Dantrolene reduced VT inducibility, improved cardiac function, and reduced fibrosis. J Mol Cell Cardiol. 2023 Aug;181:67-78.
Mdx mice Duchenne muscular dystrophy model Oral 30–70 mg/kg Daily for 6 months Assessed the effect of dantrolene/AON combination on DMD exon-23 skipping, showing dantrolene significantly boosted exon skipping and dystrophin rescue while reducing muscle pathology Mol Ther Nucleic Acids. 2018 Jun 1;11:180-191
Mice YAC128 HD transgenic Mice model Oral 5 mg/kg Twice a week from 2 to 11.5 months of age To evaluate the effects of dantrolene on motor coordination and neuropathology in YAC128 mice, results showed that long-term dantrolene feeding significantly improved motor coordination, reduced striatal neuronal loss, and decreased Htt nuclear aggregate formation Mol Neurodegener. 2011 Nov 25;6:81.
C57BL/6J mice PS19 tau transgenic mice Intranasal administration 5 mg/kg Once daily, 5 days/week, for 3 months To investigate the effects of intranasal ERFR on cognitive function in PS19 tau transgenic mice, showing no significant changes in cognition, olfaction, or motor function after chronic treatment. J Alzheimers Dis. 2024;98(2):549-562

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.25mL

0.25mL

0.13mL

6.26mL

1.25mL

0.63mL

12.52mL

2.50mL

1.25mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories